New study tracks muscle loss in cancer patients to uncover hidden clues

NCT ID NCT05642819

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study follows 200 people with cancers of the esophagus, stomach, pancreas, colon, or rectum who are scheduled for surgery, along with some healthy controls. Researchers will track weight, muscle mass, physical activity, quality of life, and immune markers over a year to better understand cachexia—a condition causing muscle wasting and fatigue. The goal is to get a complete picture of how cachexia develops and changes over time, which could help improve care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this study could lead to better ways to detect and track cachexia early in cancer patients, potentially improving treatment and quality of life.
What could go wrong
This is an observational study, not testing a new treatment. It may not directly lead to new therapies, and results may not apply to all cancer types.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CACHEXIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Edinburgh

    RECRUITING

    Edinburgh, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.